Effectiveness of Anti-Dementia Drugs in Extremely Severe Alzheimer’s Disease: A 12-Week, Multicenter, Randomized, Single-Blind Study-Reference-Cited by-同舟云学术

Effectiveness of Anti-Dementia Drugs in Extremely Severe Alzheimer’s Disease: A 12-Week, Multicenter, Randomized, Single-Blind Study

Published:2018-05-08 Issue:3 Volume:63 Page:1035-1044
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Hong Yun Jeong¹,Choi Seong Hye²,Jeong Jee Hyang³,Park Kyung Won⁴,Na Hae Ri⁵

Affiliation:

1. Biomedical Research Institute, Pusan National University Hospital, Pusan, South Korea

2. Department of Neurology, Inha University School of Medicine, Incheon, South Korea

3. Department of Neurology, Ewha Womans University Mokdong Hospital, Ewha Womans University School of Medicine, Seoul, South Korea

4. Department of Neurology, Cognitive Disorders and Dementia Center, Dong-A University College of Medicine and Institute of Convergence Bio-Health, Pusan, South Korea

5. Department of Neurology, Bobath Memorial Hospital, Seongnam, South Korea

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference39 articles.

1. Diagnosis of Alzheimer’s disease. Report of an International Psychogeriatric Association Special Meeting Work Group under the cosponsorship of Alzheimer’s Disease International, the European Federation of Neurological Societies, the World Health Organization, and the World Psychiatric Association;Reisberg;Int Psychogeriatr,1997

2. Trajectories of disability in the last year of life;Gill;N Engl J Med,2010

3. The Global Deterioration Scale for assessment of primary degenerative dementia;Reisberg;Am J Psychiatry,1982

4. Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer’s disease: A systematic review and meta-analysis;Tan;J Alzheimers Dis,2014

5. The effects of donepezil in Alzheimer’s disease- results from a multinational trial;Burns;Dement Geriatr Cogn Disord,1999

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-dementia drugs: what is the evidence in advanced stages?;Porto Biomedical Journal;2024-03

2. Tools for deprescribing in severe dementia: A scoping review;International Journal of Geriatric Psychiatry;2023-07

3. The Dose and Duration-dependent Association between Melatonin Treatment and Overall Cognition in Alzheimer’s Dementia: A Network Meta- Analysis of Randomized Placebo-Controlled Trials;Current Neuropharmacology;2022-10

4. Anti-dementia Medications: Course and Duration of Therapy and Withdrawal Syndromes;NeuroPsychopharmacotherapy;2022

5. Procyanidine resists the fibril formation of human islet amyloid polypeptide;International Journal of Biological Macromolecules;2021-07